Zura Bio ZURA
NASDAQ ZURA
$4.11 -0.03 (-0.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zura Bio (ZURA) Gains from Sales and Divestitures (2026)

Updated

Zura Bio (ZURA) recorded Gains from Sales and Divestitures of $2,995 in Q2 2026.

Analysis

Zura Bio (ZURA) Gains from Sales and Divestitures (2026) Analysis & Trends

On a TTM basis, Zura Bio's Gains from Sales and Divestitures came in at -$5.00 as of Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Zura Bio 521.16 Mn 521.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,995.00
Mar 31, 2026 -3,000.00
API Access

Zura Bio Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ZURA&period=max&api_key=YOUR_API_KEY